Retrospective analysis on incidence and risk factors of post-transplant diabetes mellitus after lung transplantation and its association with clinical outcomes
Transplant Immunology · 2024-04 · 83 · 102008
DOI: 10.1016/j.trim.2024.102008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Immunology, 2024-04. Verfasst von Wenwen Du und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, China-Japan Friendship Hospital, Chaoyang District, Beijing, China. Hauptthemen laut MEDLINE: Kidney Transplantation, Diabetes Mellitus, Lung Transplantation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China-Japan Friendship Hospital, CAMS Innovation Fund for Medical Sciences.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND: Post-transplant diabetes mellitus (PTDM) is a common complication after transplantation. We aim to explore potential risk factors of PTDM and its association with outcomes after lung transplantation (LTx). METHODS: A retrospective study was conducted in 100 patients who underwent LTx at our institution from 2017 to 2021. Patients' information was collected, and genotyping for single nucleotide polymorphisms known to potentially increase the risk of Type 2 DM was performed. Univariate and multivariate analyses were conducted to identify risk factors for PTDM. The primary outcome was the incidence of PTDM. Secondary outcomes were associations between PTDM and clinical outcomes following LTx. RESULTS: Thirty-nine patients (39.0%) developed PTDM, while 10 patients (25.6%) recovered subsequently. The incidence of PTDM was associated with age > 45 (HR: 2.919, 95% CI [1.021-8.348]), pre-transplant HbA1c > 5.7% (HR: 2.344, 95% CI [1.201-4.573]), KCNJ11 rs5215 (HR: 2.090, 95% CI [1.050-4.162]) and tacrolimus concentration > 8 ng/mL in the first month (HR: 2.090, 95% CI [1.050-4.162]). Patients with PTDM experienced elevated fasting blood glucose levels (FBG) during the first month post-transplantation (p < 0.001), and required a longer duration for FBG to return to normal levels (p < 0.001). However, the presence of PTDM did not significantly impact renal function, incidence of infection episodes, chronic lung allograft dysfunction or mortality following LTx. CONCLUSION: Advanced age, elevated HbA1c levels, KCNJ11 gene polymorphism, and early exposure to tacrolimus are all significant risk factors for PTDM following LTx. The clinical implications of these factors warrant attention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, China-Japan Friendship Hospital, Chaoyang District, Beijing, China.
- Department of Pharmacy, China-Japan Friendship Hospital, Chaoyang District, Beijing, China; Department of Dermatology, China-Japan Friendship Hospital, Chaoyang District, Beijing, China. Electronic address: zuoxianbo@qq…
Förderung
- National Natural Science Foundation of China
- China-Japan Friendship Hospital
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Du, W., Wang, X., Zhang, D., & Zuo, X. (2024). Retrospective analysis on incidence and risk factors of post-transplant diabetes mellitus after lung transplantation and its association with clinical outcomes. Transplant Immunology, 83, 102008. https://doi.org/10.1016/j.trim.2024.102008
Vancouver
Du W, Wang X, Zhang D, Zuo X. Retrospective analysis on incidence and risk factors of post-transplant diabetes mellitus after lung transplantation and its association with clinical outcomes. Transplant Immunology. 2024;83:102008. doi:10.1016/j.trim.2024.102008
BibTeX
@article{Du2024,
author = {Du, Wenwen and Wang, Xiaoxing and Zhang, Dan and Zuo, Xianbo},
title = {Retrospective analysis on incidence and risk factors of post-transplant diabetes mellitus after lung transplantation and its association with clinical outcomes},
journal = {Transplant Immunology},
year = {2024},
volume = {83},
pages = {102008},
doi = {10.1016/j.trim.2024.102008}
}
EUVIMED